NCT02063035View on ClinicalTrials.gov

Effectiveness Study of the Drug Tranexamic Acid to Reduce Post-surgery Blood Loss in Spinal Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

April 22, 2015

Study Completion Date

April 22, 2015

Conditions
Lumbar Spinal StenosisThoracic Spinal Stenosis
Interventions
DRUG

Tranexamic Acid

A single topical application of 3 grams (g) of Tranexamic acid in 100 milliliter (mL) saline.

DRUG

Placebo

A single topical application of matching placebo, which is 100 mL of normal saline.

Trial Locations (1)

02114

Massachusetts General Hospital Orthopedic Spine, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT02063035 - Effectiveness Study of the Drug Tranexamic Acid to Reduce Post-surgery Blood Loss in Spinal Surgery | Biotech Hunter | Biotech Hunter